Physician profile
Sumana Koduri
NPI 1942252762
$6,746.43
in general payments reported to CMS, 2019-2025
48 companies · $2,631 in 2025
The $2,631 reported for 2025 was more than what a typical Urogynecology and Reconstructive Pelvic Surgery (Urology) provider received nationally (typical 2025 total: $782).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $504 · 2020: $61.49 · 2021: $213 · 2022: $287 · 2023: $1,109 · 2024: $1,941 · 2025: $2,631.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,384 · Consulting Fee: $788 · Travel and Lodging: $509.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,383.89 |
| Consulting Fee | $787.50 |
| Travel and Lodging | $509.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,765.34 | 2021-2025 | Nuro, Altaviva, Ellipsys Vascular Access System |
| Boston Scientific Corporation | $1,114.24 | 2019-2025 | Axonics, Solyx Sis System, Upsylon |
| Axonics, INC. | $575.90 | 2022-2024 | Axonics, Bulkamid |
| Abbott Laboratories | $410.32 | 2024-2025 | Perclose Prostyle, Jot Dx, Thoratec Heartmate 3 Lvas Implant Kit |
| Caldera Medical, INC | $363.05 | 2019 | |
| Smith+Nephew, INC. | $248.27 | 2024 | Grafix Pl, Stravix, Oasis |
| Organogenesis INC. | $213.39 | 2024-2025 | Puraply Am, Simplimax |
| Novo Nordisk INC | $135.66 | 2024-2025 | Wegovy, Ozempic |
| Novartis Pharmaceuticals Corporation | $126.13 | 2023-2025 | |
| Therapeuticsmd, INC. | $125.00 | 2019 | |
| Abbvie INC. | $116.88 | 2024-2025 | |
| Cvrx, INC. | $104.22 | 2024 | Barostim Neo System |
| Astrazeneca Pharmaceuticals LP | $103.00 | 2024-2025 | Farxiga, Wainua |
| Heartflow, INC. | $95.38 | 2024-2025 | |
| Alnylam Pharmaceuticals INC. | $92.01 | 2024-2025 | Onpattro |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $83.93 | 2023 | Cios Alpha, Artis Zee Multi-Purpose |
| E.R. Squibb & Sons, L.L.C. | $81.56 | 2023 | Camzyos |
| Vertex Pharmaceuticals Incorporated | $76.10 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $69.88 | 2024-2025 | Verquvo, Winrevair |
| Kerecis Limited | $62.10 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| United Therapeutics Corporation | $49.56 | 2025 | Tyvaso |
| Paratek Pharmaceuticals, INC. | $45.50 | 2024 | Nuzyra |
| Lantheus Medical Imaging, INC. | $43.73 | 2024-2025 | |
| Pfizer INC. | $43.53 | 2024-2025 | |
| Bridgebio Pharma, INC. | $39.75 | 2025 | Attruby |
| Astellas Pharma US INC | $38.21 | 2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $36.89 | 2025 | |
| Laborie Medical Technologies Corp. | $34.43 | 2024-2025 | Eclipse |
| Baxter Healthcare | $32.73 | 2024 | Perclot, Hillrom - Cardiac Ambulatory Monitor |
| Applied Medical Resources Corporation | $32.38 | 2024 | |
| Kiniksa Pharmaceuticals International, Plc | $31.32 | 2024 | Arcalyst |
| Irhythm Technologies, INC. | $27.31 | 2024 | Zio Xt Patch, Zio Monitor |
| Biomerieux INC | $26.00 | 2025 | Biofire Spotfire Respiratory/Sore Throat (R/St) Panel |
| Sumitomo Pharma America, INC. | $24.40 | 2025 | Gemtesa |
| Valencia Technologies Corporation | $23.73 | 2025 | Ecoin Device Kit |
| Cardiva Medical, INC. | $23.72 | 2024 | Cardiva Vascade 6/7f Vcs |
| Scpharmaceuticals INC. | $23.53 | 2024 | |
| Amgen INC. | $22.53 | 2025 | Otezla, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $22.36 | 2024 | Lifevest |
| Surmodics, INC. | $22.04 | 2025 | Sublime 014 Rx Pta Balloon Dilatation Catheter, Pounce Thrombectomy, Pounce Venous Thrombectomy System |
| Becton, Dickinson and Company | $21.40 | 2023 | Rotarexs 6 F X 135 Cm |
| Solventum Corporation | $21.15 | 2024 | Activ.A.C. |
| Musculoskeletal Transplant Foundation INC. | $19.28 | 2024 | |
| Henry Schein, INC. | $19.22 | 2024 | |
| Tactile Systems Technology INC | $15.68 | 2025 | Nimbl, Flexitouch Plus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.51 | 2023 | Jardiance |
| Kowa Pharmaceuticals America, INC. | $14.09 | 2024 | Zoryve |
| Amphastar Pharmaceuticals, INC. | $14.09 | 2024 | Baqsimi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sumana Koduri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.